Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA6 | P23280 | 1/20 | 0.57 |
| ▸ | PARP1 | P09874 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.50 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
| ▸ | FASN | P49327 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CLK1 | P49759 | 1/20 | 0.47 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.47 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10389972 | 0.87 | SMN1; SMN2 (0.54) | ALDH1A1MAPTGAASMN1; SMN2L3MBTL1 | |
| SCHEMBL28422314 | 0.85 | KDM4E (0.53) | CA12CA2CA9CA1CA6 | |
| SCHEMBL2026598 | 0.84 | HSD17B3 (0.60) | CA12CA2CA9CA1CA6 | |
| SCHEMBL8477068 | 0.82 | SMYD3 (0.42) | CA12CA2CA9CA1CA6 | |
| SCHEMBL4637871 | 0.81 | HSD17B3 (0.62) | CA12CA2CA9CA1CA6 | |
| SCHEMBL30497947 | 0.81 | CA12 (0.59) | CA12CA2CA9CA1CA6 | |
| SCHEMBL108054 | 0.81 | CA12 (0.59) | CA12CA2CA9CA1CA6 | |
| SCHEMBL25911130 | 0.80 | KDM4E (0.56) | CA12CA2CA9CA1CA6 | |
| SCHEMBL28837428 | 0.80 | MAPT (0.58) | MAPTSMN1; SMN2L3MBTL1ESR1MEN1 | |
| SCHEMBL10632540 | 0.80 | HSD17B3 (0.64) | ALDH1A1CTNNB1MAPTESR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118685463-B | Dapoxetine chiral intermediates of statins enzymatic synthesis of bodies | 杭州微远生物科技有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| CN-118666695-B | Synthesis method of meta-hydroxylamine bitartrate | 玉门千华制药有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-118685463-A | Dapoxetine chiral intermediates of statins enzymatic synthesis of bodies | 杭州微远生物科技有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-118666696-A | Synthesis and refining method of meta-hydroxylamine bitartrate | 玉门千华制药有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-118666695-A | Synthesis method of meta-hydroxylamine bitartrate | 玉门千华制药有限公司 | 2024-09-20 | — | — | CN | claimed |
| US-8552219-B2 | Process for preparing L-phenyl-3-dimethylaminopropane derivative | IND-SWIFT LABORATORIES LIMITED (IN) | 2013-10-08 | — | — | US | claimed |
| US-20130190522-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | IND-SWIFT LABORATORIES LIMITED (IN) | 2013-07-25 | — | — | US | claimed |
| US-20130096347-A1 | NOVEL PROCESS FOR PREPARING HIGHLY PURE TAPENTADOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2013-04-18 | — | — | US | claimed |
| EP-2556048-A2 | NOVEL PROCESS FOR PREPARING HIGHLY PURE TAPENTADOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Actavis Group PTC EHF (IS) | 2013-02-13 | — | — | EP | claimed |
| US-20060265818-A1 | At least two oxidation dye precursors, at least one of which must be of the developer type or at least two oxo dye precursors, at least one of which must be a reactive carbonyl compound; hair dyes producing uniform and natural-looking, lightened color reflections | HENKEL KOMMANDITGESELLSCHAFT AUF AKLLEN (HENKEL KGAA) (DE) | 2006-11-30 | — | — | US | claimed |
| EP-1432428-B1 | Agent for colouring fibres containing keratin | HENKEL KGAA (DE) | 2006-11-02 | — | — | EP | claimed |
| EP-1433469-B1 | Composition for dyeing keratinous fibres | HENKEL KGAA (DE) | 2006-10-11 | — | — | EP | claimed |
| US-7105032-B2 | Agents used for dyeing keratinous fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-09-12 | — | — | US | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| US-20050271608-A1 | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives | GUPTA SHYAM K | 2005-12-08 | — | — | US | claimed |
| US-20050262647-A1 | Agent for dyeing fibers containing keratin | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2005-12-01 | — | — | US | claimed |
| EP-1434557-B1 | AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-11-09 | — | — | EP | claimed |
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2005-07-07 | — | — | US | claimed |
| WO-1993010071-A1 | PROCESS FOR THE PRODUCTION OF CARBONYLS | CATALYTICA, INC. (US) | 1993-05-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190522-A1 | PROCESS FOR PREPARING L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVE | CYP3A43, UGT1A1, UGT1A7 | CA12 4711/4885CA2 4765/4885CA9 3999/4885 |
| US-20050144740-A1 | Agents used for dyeing keratinous fibers | KRT18, TUBB3, DSG1 | CA12 1931/4885CA2 2517/4885CA9 1985/4885 |
| US-20060265818-A1 | At least two oxidation dye precursors, at least one of which must be of the developer type or at least two oxo dye precursors, at least one of which must be a reactive carbonyl compound; hair dyes producing uniform and natural-looking, lightened color reflections | KRT18, CUTA, PLOD2 | CA12 202/4885CA2 603/4885CA9 1464/4885 |
| US-20050262647-A1 | Agent for dyeing fibers containing keratin | KRT18, CKAP4, KRTCAP2 | CA12 140/4885CA2 579/4885CA9 364/4885 |
| US-20130096347-A1 | NOVEL PROCESS FOR PREPARING HIGHLY PURE TAPENTADOL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | TPMT, OPRD1, COMT | CA12 3477/4885CA2 1048/4885CA9 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.